This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Espinel-Ingroff, A.
Right arrow Articles by Wang, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Espinel-Ingroff, A.
Right arrow Articles by Wang, A.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, June 2007, p. 1811-1820, Vol. 45, No. 6
0095-1137/07/$08.00+0     doi:10.1128/JCM.00134-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Multicenter Evaluation of a New Disk Agar Diffusion Method for Susceptibility Testing of Filamentous Fungi with Voriconazole, Posaconazole, Itraconazole, Amphotericin B, and Caspofungin{triangledown}

A. Espinel-Ingroff,1* B. Arthington-Skaggs,2 N. Iqbal,2 D. Ellis,3 M. A. Pfaller,4 S. Messer,4 M. Rinaldi,5 A. Fothergill,5 D. L. Gibbs,6 and A. Wang6

Virginia Commonwealth University Medical Center, Richmond, Virginia,1 Centers for Disease Control, Atlanta, Georgia,2 Women's and Children's Hospital, North Adelaide, South Australia, Australia,3 University of Iowa, Iowa City, Iowa,4 University of Texas, San Antonio, Texas,5 Giles Scientific Inc., Santa Barbara, California6

Received 18 January 2007/ Returned for modification 9 March 2007/ Accepted 2 April 2007

The purpose of this study was to correlate inhibition zone diameters, in millimeters (agar diffusion disk method), with the broth dilution MICs or minimum effective concentrations (MECs) (CLSI M38-A method) of five antifungal agents to identify optimal testing guidelines for disk mold testing. The following disk diffusion testing parameters were evaluated for 555 isolates of the molds Absidia corymbifera, Aspergillus sp. (five species), Alternaria sp., Bipolaris spicifera, Fusarium sp. (three species), Mucor sp. (two species), Paecilomyces lilacinus, Rhizopus sp. (two species), and Scedosporium sp. (two species): (i) two media (supplemented Mueller-Hinton agar [2% dextrose and 0.5 µg/ml methylene blue] and plain Mueller-Hinton [MH] agar), (ii) three incubation times (16 to 24, 48, and 72 h), and (iii) seven disks (amphotericin B and itraconazole 10-µg disks, voriconazole 1- and 10-µg disks, two sources of caspofungin 5-µg disks [BBL and Oxoid], and posaconazole 5-µg disks). MH agar supported better growth of all of the species tested (24 to 48 h). The reproducibility of zone diameters and their correlation with either MICs or MECs (caspofungin) were superior on MH agar (91 to 100% versus 82 to 100%; R, 0.71 to 0.93 versus 0.53 to 0.96 for four of the five agents). Based on these results, the optimal testing conditions for mold disk diffusion testing were (i) plain MH agar; (ii) incubation times of 16 to 24 h (zygomycetes), 24 h (Aspergillus fumigatus, A. flavus, and A. niger), and 48 h (other species); and (iii) the posaconazole 5-µg disk, voriconazole 1-µg disk, itraconazole 10-µg disk (for all except zygomycetes), BBL caspofungin 5-µg disk, and amphotericin B 10-µg (zygomycetes only).


* Corresponding author. Mailing address: Virginia Commonwealth University Medical Center, Richmond, VA 23298-0049. Phone: (804) 828-5743. Fax: (804) 828-3097. E-mail: avingrof{at}vcu.edu

{triangledown} Published ahead of print on 11 April 2007.


Journal of Clinical Microbiology, June 2007, p. 1811-1820, Vol. 45, No. 6
0095-1137/07/$08.00+0     doi:10.1128/JCM.00134-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Morris, M. I. (2009). Posaconazole: A new oral antifungal agent with an expanded spectrum of activity. Am J Health Syst Pharm 66: 225-236 [Abstract] [Full Text]  
  • Lass-Florl, C., Alastruey-Izquierdo, A., Cuenca-Estrella, M., Perkhofer, S., Rodriguez-Tudela, J. L. (2009). In Vitro Activities of Various Antifungal Drugs against Aspergillus terreus: Global Assessment Using the Methodology of the European Committee on Antimicrobial Susceptibility Testing. Antimicrob. Agents Chemother. 53: 794-795 [Abstract] [Full Text]  
  • Araujo, R., Coutinho, I., Espinel-Ingroff, A. (2008). Rapid method for testing the susceptibility of Aspergillus fumigatus to amphotericin B, itraconazole, voriconazole and posaconazole by assessment of oxygen consumption. J Antimicrob Chemother 62: 1277-1280 [Abstract] [Full Text]  
  • Maida, C. M., Milici, M. E., Trovato, L., Oliveri, S., Amodio, E., Spreghini, E., Scalise, G., Barchiesi, F. (2008). Evaluation of the Disk Diffusion Method Compared to the Microdilution Method in Susceptibility Testing of Anidulafungin against Filamentous Fungi. J. Clin. Microbiol. 46: 4071-4074 [Abstract] [Full Text]  
  • Espinel-Ingroff, A., Canton, E. (2008). Comparison of Neo-Sensitabs Tablet Diffusion Assay with CLSI Broth Microdilution M38-A and Disk Diffusion Methods for Testing Susceptibility of Filamentous Fungi with Amphotericin B, Caspofungin, Itraconazole, Posaconazole, and Voriconazole. J. Clin. Microbiol. 46: 1793-1803 [Abstract] [Full Text]  
  • Espinel-Ingroff, A., Johnson, E., Hockey, H., Troke, P. (2008). Activities of voriconazole, itraconazole and amphotericin B in vitro against 590 moulds from 323 patients in the voriconazole Phase III clinical studies. J Antimicrob Chemother 61: 616-620 [Abstract] [Full Text]  
  • Milici, M. E., Maida, C. M., Spreghini, E., Ravazzolo, B., Oliveri, S., Scalise, G., Barchiesi, F. (2007). Comparison between Disk Diffusion and Microdilution Methods for Determining Susceptibility of Clinical Fungal Isolates to Caspofungin. J. Clin. Microbiol. 45: 3529-3533 [Abstract] [Full Text]